SF
Therapeutic Areas
CorFlow Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CoFI System for MVO | Microvascular Obstruction in ST-elevation myocardial infarction (STEMI) patients | Pivotal Trial |
Leadership Team at CorFlow Therapeutics
PG
Paul G. Mead
CEO
DA
Duraid Antone
COO
RB
Reeder Beks
CFO
MB
Markus Bütler
Head of Quality
LB
Lukas Bereuter
Head of Product Development
EV
Emma van Eeden
Head of Medical Affairs and Market Development
OB
Oliver Bludau
Head of Operations and Supplier Engineering
RW
Reggie Walton
Head of US Clinical Operations